Literature DB >> 2149271

Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis.

A D MBewu1, P N Durrington.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2149271     DOI： 10.1016/0021-9150(90)90177-k

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  35 in total

1.  Analysis of Drug Interactions with Lipoproteins by High-Performance Affinity Chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Adv Med Biol       Date:  2012

2.  Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.

Authors:  E Farish; H A Rolton; J F Barnes; D M Hart
Journal:  BMJ       Date:  1991-09-21

3.  A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine.

Authors:  K M Wasan; S M Cassidy; M Ramaswamy; A Kennedy; F W Strobel; S P Ng; T Y Lee
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

Review 4.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

5.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

6.  Laboratory facilities for investigating lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association survey.

Authors:  M F Laker; J P Reckless; D J Betteridge; P N Durrington; J P Miller; D P Nicholls; J Shepherd; G R Thompson
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

7.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

8.  Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.

Authors:  K Saku; B Zhang; K Hirata; Y Okura; H Bai; R Liu; K Arakawa
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

10.  Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.

Authors:  G F Watts; E M Kearney; N A Taub; B M Slavin
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.